Cross Country Healthcare Announces Executive and Board Changes
Ticker: CCRN · Form: 8-K · Filed: May 16, 2024 · CIK: 1141103
| Field | Detail |
|---|---|
| Company | Cross Country Healthcare INC (CCRN) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: CCRN
TL;DR
CCRN board shakeup, new execs appointed.
AI Summary
Cross Country Healthcare, Inc. announced on May 14, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives.
Why It Matters
Changes in leadership and board composition can signal shifts in company strategy, governance, or future performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational direction.
Key Numbers
- 0-33169 — Commission File Number (Identifies the SEC filing for Cross Country Healthcare, Inc.)
- 13-4066229 — I.R.S. Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Cross Country Healthcare, Inc. (company) — Registrant
- May 14, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 6551 Park of Commerce Boulevard, N.W. (address) — Principal Executive Office
- Boca Raton, FL 33487 (address) — Principal Executive Office Location
FAQ
What specific roles have been affected by the executive and director changes?
The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for certain officers, but does not specify the exact roles affected in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 14, 2024.
What is the principal executive office address for Cross Country Healthcare, Inc.?
The principal executive office is located at 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Stats: 709 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2024-05-16 13:02:23
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share CCRN The Nasdaq Stock Market
Filing Documents
- ccrn-20240514.htm (8-K) — 26KB
- ccrn-20240514_g1.jpg (GRAPHIC) — 46KB
- 0001628280-24-023746.txt ( ) — 266KB
- ccrn-20240514.xsd (EX-101.SCH) — 2KB
- ccrn-20240514_lab.xml (EX-101.LAB) — 21KB
- ccrn-20240514_pre.xml (EX-101.PRE) — 12KB
- ccrn-20240514_htm.xml (XML) — 3KB
From the Filing
ccrn-20240514 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common stock, par value $0.0001 per share CCRN The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the Annual Meeting of Stockholders of Cross Country Healthcare, Inc. (the "Company") held on May 14, 2024 (the "Annual Meeting"), the Company's stockholders approved the Cross Country Healthcare, Inc. 2024 Omnibus Incentive Plan (the "2024 Plan"). The 2024 Plan is a long-term incentive plan that is intended to provide participants with an incentive to contribute materially to the Company's growth by aligning the economic interests of the participants with those of the Company's stockholders. Accordingly, pursuant to the 2024 Plan, awards may be granted to employees, non-employee directors, consultants, and key advisors of the Company and its subsidiaries, including stock options (including incentive stock options and nonqualified stock options), stock appreciation rights, stock awards, stock units, other stock-based awards, and cash awards. The 2024 Plan was adopted principally to serve as a successor plan to the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (the "Prior Plan") and to increase the number of shares of Company common stock, $0.0001 par value (the "Common Stock"), reserved for equity-based awards to 2,400,000 shares of Common Stock (in addition to the share reserve amount that remained available under the Prior Plan immediately prior to the adoption of the 2024 Plan and other eligible returning shares). No awards may be granted under the 2024 Plan after May 13, 2034. It is not possible to determine specific amounts and types of awards that may be granted to eligible participants under the 2024 Plan subsequent to the Annual Meeting because the grant and payment of such awards is subject to the discretion of the Compensation Committee of the Company's Board of Directors. This summary of the 2024 Plan is qualified in its entirety by reference to the full text of the 2024 Plan, which is filed as Appendix A to the definitive proxy statement filed by the Company with the Securities and Exchange Commission (the "SEC") on April 1, 2024 and in the revised definitive proxy statement filed by the Company with the SEC on April 4, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CROSS COUNTRY HEALTHCARE, INC. Dated: May 16, 2024 By: /s/ William J. Burns Name: William J. Burns Title: Executive Vice President & Chief Financial Officer